Sex hormones reduce NNK detoxification through inhibition of short-chain dehydrogenases/reductases and aldo-keto reductases in vitro

• Published in: Chemico-biological interactions 2017-10, Vol.276, p.167-173
• Main Authors: Stapelfeld, Claudia, Maser, Edmund
• Format: Article
• Language: English
• Subjects: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK); Aldo-keto reductases (AKR); Aldo-Keto Reductases - antagonists & inhibitors; Aldo-Keto Reductases - genetics; Aldo-Keto Reductases - metabolism; Androstenes - chemistry; Androstenes - metabolism; Carbonyl reduction; Carcinogens - chemistry; Carcinogens - metabolism; Enzyme inhibition; Estradiol - chemistry; Estradiol - metabolism; Gonadal Hormones - chemistry; Gonadal Hormones - metabolism; Humans; Inactivation, Metabolic; Liver - enzymology; Nicotiana - chemistry; Nicotiana - metabolism; Nitrosamines - chemistry; Nitrosamines - metabolism; Progesterone - chemistry; Progesterone - metabolism; Recombinant Proteins - biosynthesis; Recombinant Proteins - chemistry; Recombinant Proteins - isolation & purification; Sex hormones; Short Chain Dehydrogenase-Reductases - antagonists & inhibitors; Short Chain Dehydrogenase-Reductases - genetics; Short Chain Dehydrogenase-Reductases - metabolism; Short-chain dehydrogenases/reductases (SDR)
• ISSN: 0009-2797; 1872-7786
• DOI: 10.1016/j.cbi.2017.02.016

Carbonyl reduction is an important metabolic pathway for endogenous and xenobiotic substances. The tobacco specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK, nicotine-derived nitrosamine ketone) is classified as carcinogenic to humans (IARC, Group 1) and considered to play the most important role in tobacco-related lung carcinogenesis. Detoxification of NNK through carbonyl reduction is catalyzed by members of the AKR- and the SDR-superfamilies which include AKR1B10, AKR1C1, AKR1C2, AKR1C4, 11β-HSD1 and CBR1. Because some reductases are also involved in steroid metabolism, five different hormones were tested for their inhibitory effect on NNK carbonyl reduction. Two of those hormones were estrogens (estradiol and ethinylestradiol), another two hormones belong to the gestagen group (progesterone and drospirenone) and the last tested hormone was an androgen (testosterone). Furthermore, one of the estrogens (ethinylestradiol) and one of the gestagens (drospirenone) are synthetic hormones, used as hormonal contraceptives. Five of six NNK reducing enzymes (AKR1B10, AKR1C1, AKR1C2, AKR1C4 and 11β-HSD1) were significantly inhibited by the tested sex hormones. Only NNK reduction catalyzed by CBR1 was not significantly impaired. In the case of the other five reductases, gestagens had remarkably stronger inhibitory effects at a concentration of 25 μM (progesterone: 66–88% inhibition; drospirenone: 26–87% inhibition) in comparison to estrogens (estradiol: 17–51% inhibition; ethinylestradiol: 14–79% inhibition) and androgens (14–78% inhibition). Moreover, in most cases the synthetic hormones showed a greater ability to inhibit NNK reduction than the physiologic derivatives. These results demonstrate that male and female sex hormones have different inhibitory potentials, thus indicating that there is a varying detoxification capacity of NNK in men and women which could result in a different risk for developing lung cancer. •NNK detoxifying carbonyl reductases are significantly inhibited by sex hormones.•Male and female sex hormones have different inhibitory potentials.•Indication for a variable risk for man and women to develop lung cancer by smoking.